Surgical outcomes and predictors of overall survival of stage I-III appendiceal adenocarcinoma: Retrospective cohort analysis of the national cancer database

IF 2.3 4区 医学 Q3 ONCOLOGY Surgical Oncology-Oxford Pub Date : 2024-01-05 DOI:10.1016/j.suronc.2024.102034
Sameh Hany Emile , Nir Horesh , Michael R. Freund , Emanuela Silva-Alvarenga , Zoe Garoufalia , Rachel Gefen , Steven D. Wexner
{"title":"Surgical outcomes and predictors of overall survival of stage I-III appendiceal adenocarcinoma: Retrospective cohort analysis of the national cancer database","authors":"Sameh Hany Emile ,&nbsp;Nir Horesh ,&nbsp;Michael R. Freund ,&nbsp;Emanuela Silva-Alvarenga ,&nbsp;Zoe Garoufalia ,&nbsp;Rachel Gefen ,&nbsp;Steven D. Wexner","doi":"10.1016/j.suronc.2024.102034","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>This study aimed to determine predictors of overall survival (OS) after surgical treatment of stage I-III appendiceal adenocarcinoma and compare the outcomes of partial colectomy and hemicolectomy.</p></div><div><h3>Methods</h3><p><span>A retrospective analysis of the U.S. National Cancer Database (NCDB) including patients who underwent surgery for stage I-III appendiceal adenocarcinoma between 2005 and 2019 was conducted. A propensity-score matched analysis was undertaken to compare the outcomes of partial and hemicolectomy and multivariate analysis was performed to determine </span>predictive factors of OS. The main outcome was OS and its independent predictors.</p></div><div><h3>Results</h3><p>2607 patients (51.6 % male) with a mean age of 61.6 ± 13.9 years were included. 61.7 % of patients underwent hemicolectomy while 31.7 % underwent partial colectomy. After matching, partial colectomy, and hemicolectomy had similar OS (117.3 vs 117.2 months; p = 0.08), positive resection margins, short-term mortality, and 30-day readmission. The hemicolectomy group was associated with more examined lymph nodes and longer hospital stays. Older age (HR: 1.047, p &lt; 0.0001), rural residence area (HR: 3.6, p = 0.025), higher Charlson score (HR: 1.6, p = 0.016), signet-ring cell carcinoma (HR: 2.37, p = 0.009), adjuvant systemic treatment (HR: 1.55, p = 0.015), positive surgical margins (HR: 1.83, p = 0.017), positive lymph nodes number (HR: 1.09, p &lt; 0.0001), and examined lymph nodes number (HR: 0.962, p = 0.001) were independent predictors of OS.</p></div><div><h3>Conclusions</h3><p>Partial colectomy and hemicolectomy had similar OS and clinical outcomes. Older age, rural residence, higher Charlson score, signet-ring pathology, adjuvant systemic treatment, positive surgical margins, positive lymph node number, and examined lymph node number were independent predictors of OS.</p></div>","PeriodicalId":51185,"journal":{"name":"Surgical Oncology-Oxford","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Oncology-Oxford","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0960740424000021","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

This study aimed to determine predictors of overall survival (OS) after surgical treatment of stage I-III appendiceal adenocarcinoma and compare the outcomes of partial colectomy and hemicolectomy.

Methods

A retrospective analysis of the U.S. National Cancer Database (NCDB) including patients who underwent surgery for stage I-III appendiceal adenocarcinoma between 2005 and 2019 was conducted. A propensity-score matched analysis was undertaken to compare the outcomes of partial and hemicolectomy and multivariate analysis was performed to determine predictive factors of OS. The main outcome was OS and its independent predictors.

Results

2607 patients (51.6 % male) with a mean age of 61.6 ± 13.9 years were included. 61.7 % of patients underwent hemicolectomy while 31.7 % underwent partial colectomy. After matching, partial colectomy, and hemicolectomy had similar OS (117.3 vs 117.2 months; p = 0.08), positive resection margins, short-term mortality, and 30-day readmission. The hemicolectomy group was associated with more examined lymph nodes and longer hospital stays. Older age (HR: 1.047, p < 0.0001), rural residence area (HR: 3.6, p = 0.025), higher Charlson score (HR: 1.6, p = 0.016), signet-ring cell carcinoma (HR: 2.37, p = 0.009), adjuvant systemic treatment (HR: 1.55, p = 0.015), positive surgical margins (HR: 1.83, p = 0.017), positive lymph nodes number (HR: 1.09, p < 0.0001), and examined lymph nodes number (HR: 0.962, p = 0.001) were independent predictors of OS.

Conclusions

Partial colectomy and hemicolectomy had similar OS and clinical outcomes. Older age, rural residence, higher Charlson score, signet-ring pathology, adjuvant systemic treatment, positive surgical margins, positive lymph node number, and examined lymph node number were independent predictors of OS.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
I-III期阑尾腺癌的手术结果和总生存率预测因素:全国癌症数据库的回顾性队列分析
背景本研究旨在确定I-III期阑尾腺癌手术治疗后总生存期(OS)的预测因素,并比较部分结肠切除术和半结肠切除术的结果。方法对美国国家癌症数据库(NCDB)进行了回顾性分析,其中包括2005年至2019年期间接受I-III期阑尾腺癌手术治疗的患者。通过倾向分数匹配分析比较了部分切除术和半切除术的结果,并进行了多变量分析以确定OS的预测因素。主要结果是OS及其独立预测因素。结果共纳入2607名患者(51.6%为男性),平均年龄为(61.6±13.9)岁。61.7%的患者接受了半结肠切除术,31.7%的患者接受了部分结肠切除术。匹配后,部分结肠切除术和半结肠切除术的手术时间(117.3 个月 vs 117.2 个月;P = 0.08)、切除边缘阳性率、短期死亡率和 30 天再入院率相似。半结肠切除术组的淋巴结检查更多,住院时间更长。年龄较大(HR:1.047,p <0.0001)、居住在农村地区(HR:3.6,p = 0.025)、Charlson评分较高(HR:1.6,p = 0.016)、标志环细胞癌(HR:2.37,p = 0.009)、辅助全身治疗(HR:1.55,p = 0.015)、手术切缘阳性(HR:1.83,p = 0.017)、阳性淋巴结数(HR:1.09,p <0.0001)和检查淋巴结数(HR:0.962,p = 0.001)是OS的独立预测因素。结论部分结肠切除术和半结肠切除术具有相似的OS和临床结局。年龄较大、居住在农村、Charlson评分较高、标志环病理、辅助全身治疗、手术切缘阳性、阳性淋巴结数和检查淋巴结数是预测OS的独立因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Surgical Oncology-Oxford
Surgical Oncology-Oxford 医学-外科
CiteScore
4.50
自引率
0.00%
发文量
169
审稿时长
38 days
期刊介绍: Surgical Oncology is a peer reviewed journal publishing review articles that contribute to the advancement of knowledge in surgical oncology and related fields of interest. Articles represent a spectrum of current technology in oncology research as well as those concerning clinical trials, surgical technique, methods of investigation and patient evaluation. Surgical Oncology publishes comprehensive Reviews that examine individual topics in considerable detail, in addition to editorials and commentaries which focus on selected papers. The journal also publishes special issues which explore topics of interest to surgical oncologists in great detail - outlining recent advancements and providing readers with the most up to date information.
期刊最新文献
Machine learning in cancer prognostication: Limitations and opportunities. Bilobed lateral artery perforator-based flap for partial breast reconstruction - Technique description and results from a ten-year cohort. Individualizing care for patients with gallbladder cancer Natural history of salivary gland secretory carcinoma: A REFCOR study. Tumor necrosis drives prognosis in osteosarcoma: No difference in chemotherapy response and survival between chondroblastic and osteoblastic osteosarcoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1